Choice Of Place Of Death From Cancer.
Doctors who would decide hospice be concerned for themselves if they were dying from cancer are more likely to discuss such care with patients in that situation, a brand-new study finds in Dec 2013. And while the majority of doctors in the study said they would aspire hospice care if they were dying from cancer, less than one-third of those said they would discuss hospice care with terminally ruin cancer patients at an early stage of care. Researchers surveyed nearly 4400 doctors who keeping for cancer patients, including primary care physicians, surgeons, oncologists, emanation oncologists and other specialists. They were asked if they would want hospice care if they were terminally ill with cancer.
They were also asked when they would talk over hospice care with a patient with terminal cancer who had four to six months to alight but had no symptoms: immediately; when symptoms first appear; when there are no more cancer treatment options; when the patient is admitted to hospital; or when the stoical or family asks about hospice care. In terms of seeking hospice heedfulness themselves, 65 percent of doctors were strongly in favor and 21 percent were a bit in favor.
Sunday 20 April 2014
Friday 18 April 2014
Sociologists Have Found New Challenges In Cancer Treatment
Sociologists Have Found New Challenges In Cancer Treatment.
Money problems can baulk women from getting recommended bust cancer treatments, a new study suggests Dec 2013. Researchers analyzed details from more than 1300 women in the Seattle-Puget Sound scope who were diagnosed with breast cancer between 2004 and 2011. The purpose was to see if their care met US National Comprehensive Cancer Network therapy guidelines.
Women who had a break in their health insurance coverage were 3,5 times more able than those with uninterrupted coverage to not receive the recommended care, the findings showed. Compared to patients with an annual kindred income of more than $90000, those with an annual family income of less than $50000 were more than twice as odds-on to not receive recommended radiation therapy. In addition, the investigators found that lower-income women were nearly five times more promising to not receive recommended chemotherapy and nearly four times more indubitably to not receive recommended endocrine therapy.
Money problems can baulk women from getting recommended bust cancer treatments, a new study suggests Dec 2013. Researchers analyzed details from more than 1300 women in the Seattle-Puget Sound scope who were diagnosed with breast cancer between 2004 and 2011. The purpose was to see if their care met US National Comprehensive Cancer Network therapy guidelines.
Women who had a break in their health insurance coverage were 3,5 times more able than those with uninterrupted coverage to not receive the recommended care, the findings showed. Compared to patients with an annual kindred income of more than $90000, those with an annual family income of less than $50000 were more than twice as odds-on to not receive recommended radiation therapy. In addition, the investigators found that lower-income women were nearly five times more promising to not receive recommended chemotherapy and nearly four times more indubitably to not receive recommended endocrine therapy.
Monday 14 April 2014
Doctors Recommend A New Drug For The Prevention Of HIV Infection
Doctors Recommend A New Drug For The Prevention Of HIV Infection.
Should bodies in hazard of contracting HIV because they have risky sex rent a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of deliberation on this question, a new international study suggests the medication doesn't lead relatives to stop using condoms or have more sex with more people. The research isn't definitive, and it hasn't changed the intention of every expert. But one of the study's co-authors said the findings support the drug's use as a method to prevent infection with HIV, the virus that causes AIDS.
And "People may have more partners or stop using condoms, but as well as we can tell, it's not because of taking the cure-all to prevent HIV infection ," said study co-author Dr Robert Grant, a elder investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in dispute is called Truvada, which combines the drugs emtricitabine and tenofovir. It's normally Euphemistic pre-owned to treat people who are infected with HIV, but research - in garish and bisexual men and in straight couples with one infected partner - have shown that it can lower the risk of infection in grass roots who become exposed to the virus through sex.
However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the medicine for prevention purposes in 2012. Few people seem to be taking it for control purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 people are taking the drug for that sense in the United States, Grant said. In the new study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.
The turn over participants, who all faced lofty risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an idle placebo. Those who believed they were taking Truvada "were just as right as all else," Grant said, suggesting that they weren't more likely to stop using condoms or be more promiscuous because they believed they had amazingly protection against HIV infection.
Should bodies in hazard of contracting HIV because they have risky sex rent a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of deliberation on this question, a new international study suggests the medication doesn't lead relatives to stop using condoms or have more sex with more people. The research isn't definitive, and it hasn't changed the intention of every expert. But one of the study's co-authors said the findings support the drug's use as a method to prevent infection with HIV, the virus that causes AIDS.
And "People may have more partners or stop using condoms, but as well as we can tell, it's not because of taking the cure-all to prevent HIV infection ," said study co-author Dr Robert Grant, a elder investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in dispute is called Truvada, which combines the drugs emtricitabine and tenofovir. It's normally Euphemistic pre-owned to treat people who are infected with HIV, but research - in garish and bisexual men and in straight couples with one infected partner - have shown that it can lower the risk of infection in grass roots who become exposed to the virus through sex.
However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the medicine for prevention purposes in 2012. Few people seem to be taking it for control purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 people are taking the drug for that sense in the United States, Grant said. In the new study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.
The turn over participants, who all faced lofty risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an idle placebo. Those who believed they were taking Truvada "were just as right as all else," Grant said, suggesting that they weren't more likely to stop using condoms or be more promiscuous because they believed they had amazingly protection against HIV infection.
Tuesday 8 April 2014
Nutritionists Provide Recommendations About Food
Nutritionists Provide Recommendations About Food.
Healthier eating, losing ballast and getting more bring to bear are among the most common New Year's resolutions, and it's important to make a chart and be patient to achieve these goals, an expert says Dec 2013. If you decide to beginning eating healthier, it can be difficult to decide where to start. It's best to focus on specific changes to pressurize your goal more attainable, said Kelly Hogan, a clinical dietitian at Mount Sinai Hospital in New York City.
Here are some examples: Replace fried chicken or fish with baked or broiled versions two or three times a week; snack four or five servings of vegetables every weekday; and cook dinner at residency three nights a week a substitute of ordering carry-out food. Instead of stern out all your nightly desserts, plan to have one small dessert one or two nights per week.
Healthier eating, losing ballast and getting more bring to bear are among the most common New Year's resolutions, and it's important to make a chart and be patient to achieve these goals, an expert says Dec 2013. If you decide to beginning eating healthier, it can be difficult to decide where to start. It's best to focus on specific changes to pressurize your goal more attainable, said Kelly Hogan, a clinical dietitian at Mount Sinai Hospital in New York City.
Here are some examples: Replace fried chicken or fish with baked or broiled versions two or three times a week; snack four or five servings of vegetables every weekday; and cook dinner at residency three nights a week a substitute of ordering carry-out food. Instead of stern out all your nightly desserts, plan to have one small dessert one or two nights per week.
Thursday 3 April 2014
Skin Color Affects The Rate Of Weight Loss
Skin Color Affects The Rate Of Weight Loss.
Black women will dissipate less moment than white women even if they follow the exact same exercise and diet regimen, researchers report. The rationality behind this finding is that black women's metabolisms run more slowly, which decreases their commonplace energy burn, said study author James DeLany, an associate professor in the dividing of endocrinology and metabolism at the University of Pittsburgh School of Medicine. "African-American women have a further energy expenditure. They're going to have to eat fewer calories than they would if they were Caucasian, and/or prolong their physical activity more," said DeLany.
His report is published in the Dec 20, 2013 end of the International Journal of Obesity. DeLany and his colleagues reached this conclusion during a weight-loss look involving severely obese white and black women. Previous studies have shown that black women spend less weight, and the researchers set out to verify those findings. The research included 66 snow-white and 69 black women, who were placed on the same calorie-restricted diet of an average of 1800 calories a epoch for six months.
They also were assigned the same exercise schedule. The black women lost about 8 pounds less, on average, than the cadaverous women, the researchers found. The explanation can't be that baleful women didn't adhere to the diet and exercise plan. The researchers closely tracked the calories each maid ate and the calories they burned through exercise, and found that black and white women stuck to the program equally. "We found the African-American women and the Caucasian women were both eating nearly comparable amounts of calories.
They were as adherent in real activity as well". That leaves variations in biology and metabolism to spell out the difference in weight-loss success, the study authors said. "The African-American women are equally as adherent to the behavioral intervention. It's just that the weight-loss instruction is wrong because it's based on the assumption that the requirements are the same".
Black women will dissipate less moment than white women even if they follow the exact same exercise and diet regimen, researchers report. The rationality behind this finding is that black women's metabolisms run more slowly, which decreases their commonplace energy burn, said study author James DeLany, an associate professor in the dividing of endocrinology and metabolism at the University of Pittsburgh School of Medicine. "African-American women have a further energy expenditure. They're going to have to eat fewer calories than they would if they were Caucasian, and/or prolong their physical activity more," said DeLany.
His report is published in the Dec 20, 2013 end of the International Journal of Obesity. DeLany and his colleagues reached this conclusion during a weight-loss look involving severely obese white and black women. Previous studies have shown that black women spend less weight, and the researchers set out to verify those findings. The research included 66 snow-white and 69 black women, who were placed on the same calorie-restricted diet of an average of 1800 calories a epoch for six months.
They also were assigned the same exercise schedule. The black women lost about 8 pounds less, on average, than the cadaverous women, the researchers found. The explanation can't be that baleful women didn't adhere to the diet and exercise plan. The researchers closely tracked the calories each maid ate and the calories they burned through exercise, and found that black and white women stuck to the program equally. "We found the African-American women and the Caucasian women were both eating nearly comparable amounts of calories.
They were as adherent in real activity as well". That leaves variations in biology and metabolism to spell out the difference in weight-loss success, the study authors said. "The African-American women are equally as adherent to the behavioral intervention. It's just that the weight-loss instruction is wrong because it's based on the assumption that the requirements are the same".
Sunday 30 March 2014
New Treatment For Arthritis
New Treatment For Arthritis.
There's no substantiation to support the safety or effectiveness of nearly 8 percent of all components in use in hip-replacement surgeries in England and Wales, a new survey finds in Dec 2013. The University of Oxford researchers said the current regulatory transform "seems to be entirely inadequate" and called for a new system for introducing new devices. The team's fly-past of data revealed that more than 10000 of the nearly 137000 components used in beginning hip replacements in England and Wales in 2011 had no solid evidence of being effective.
These components included about 150 cemented stems, more than 900 uncemented stems, more than 1700 cemented cups and nearly 7600 uncemented cups, according to the study, which was published online Dec 19, 2013 in the newsletter BMJ. In a newspaper despatch release, researcher Sion Glyn-Jones and colleagues said their findings are of great concern, "particularly in ignition of the widespread publicity surrounding recent safety problems with rate to some resurfacing and other large-diameter metal-on-metal joint replacements".
There's no substantiation to support the safety or effectiveness of nearly 8 percent of all components in use in hip-replacement surgeries in England and Wales, a new survey finds in Dec 2013. The University of Oxford researchers said the current regulatory transform "seems to be entirely inadequate" and called for a new system for introducing new devices. The team's fly-past of data revealed that more than 10000 of the nearly 137000 components used in beginning hip replacements in England and Wales in 2011 had no solid evidence of being effective.
These components included about 150 cemented stems, more than 900 uncemented stems, more than 1700 cemented cups and nearly 7600 uncemented cups, according to the study, which was published online Dec 19, 2013 in the newsletter BMJ. In a newspaper despatch release, researcher Sion Glyn-Jones and colleagues said their findings are of great concern, "particularly in ignition of the widespread publicity surrounding recent safety problems with rate to some resurfacing and other large-diameter metal-on-metal joint replacements".
Wednesday 26 March 2014
Pears Help With Heart Disease
Pears Help With Heart Disease.
Boosting the lot of fiber in your legislature may lower your risk for heart disease, a new study finds. "With so much controversy causing many to escape carbohydrates and grains, this trial reassures us of the importance of fiber in the prevention of cardiovascular disease," said one champion not connected to the study, Dr Suzanne Steinbaum, a preventive cardiologist at Lenox Hill Hospital, in New York City. In the study, researchers led by Diane Threapleton, of the School of Food Science and Nutrition at the University of Leeds, in England, analyzed facts from the United States, Australia, Europe and Japan to assess contrasting kinds of fiber intake.
Her set looked at amount fiber; insoluble fiber (such as that found in whole grains, potato skins) soluble fiber (found in legumes, nuts, oats, barley); cereal; fruits and vegetables and other sources. The swat also looked at two categories of bravery disease. One, "coronary sentiment disease" refers to plaque buildup in the heart's arteries that could lead to a affection attack, according to the American Heart Association.
The second type of heart trouble is called "cardiovascular disease" - an brolly term for heart and blood vessel conditions that include pluck attack, stroke, heart failure and other problems, the AHA explains. The more total, insoluble, and fruit and vegetable fiber that ancestors consumed, the lower their risk of both types of heart disease, the meditate on found. Increased consumption of soluble fiber led to a greater reduction in cardiovascular disability risk than coronary heart disease risk.
Boosting the lot of fiber in your legislature may lower your risk for heart disease, a new study finds. "With so much controversy causing many to escape carbohydrates and grains, this trial reassures us of the importance of fiber in the prevention of cardiovascular disease," said one champion not connected to the study, Dr Suzanne Steinbaum, a preventive cardiologist at Lenox Hill Hospital, in New York City. In the study, researchers led by Diane Threapleton, of the School of Food Science and Nutrition at the University of Leeds, in England, analyzed facts from the United States, Australia, Europe and Japan to assess contrasting kinds of fiber intake.
Her set looked at amount fiber; insoluble fiber (such as that found in whole grains, potato skins) soluble fiber (found in legumes, nuts, oats, barley); cereal; fruits and vegetables and other sources. The swat also looked at two categories of bravery disease. One, "coronary sentiment disease" refers to plaque buildup in the heart's arteries that could lead to a affection attack, according to the American Heart Association.
The second type of heart trouble is called "cardiovascular disease" - an brolly term for heart and blood vessel conditions that include pluck attack, stroke, heart failure and other problems, the AHA explains. The more total, insoluble, and fruit and vegetable fiber that ancestors consumed, the lower their risk of both types of heart disease, the meditate on found. Increased consumption of soluble fiber led to a greater reduction in cardiovascular disability risk than coronary heart disease risk.
Sunday 23 March 2014
Elderly After Injury
Elderly After Injury.
Seniors who withstand an injury are more likely to regain their autarchy if they consult a geriatric specialist during their hospital stay, researchers report in Dec 2013. The analyse included people 65 and older with injuries ranging from a minor rib cleave from a fall to multiple fractures or head trauma suffered as a driver, passenger or pedestrian in a movement accident. A year after discharge from the hospital, the patients were asked how well they were able to perform daily activities such as walking, bathing, managing finances, gleam housework and shopping.
Those who had a consultation with a geriatrician during their asylum stay were able to return to about two-thirds more daily activities than those who did not, according to the study published recently in the Journal of the American Medical Association (JAMA) Surgery. "Trauma surgeons have wish struggled with the fragility of their older trauma patients who have much greater robustness risks for the same injuries experienced by younger patients," chief study author Dr Lillian Min, an assistant professor in the division of geriatric drug at the University of Michigan Medical School, said in a university news release.
Seniors who withstand an injury are more likely to regain their autarchy if they consult a geriatric specialist during their hospital stay, researchers report in Dec 2013. The analyse included people 65 and older with injuries ranging from a minor rib cleave from a fall to multiple fractures or head trauma suffered as a driver, passenger or pedestrian in a movement accident. A year after discharge from the hospital, the patients were asked how well they were able to perform daily activities such as walking, bathing, managing finances, gleam housework and shopping.
Those who had a consultation with a geriatrician during their asylum stay were able to return to about two-thirds more daily activities than those who did not, according to the study published recently in the Journal of the American Medical Association (JAMA) Surgery. "Trauma surgeons have wish struggled with the fragility of their older trauma patients who have much greater robustness risks for the same injuries experienced by younger patients," chief study author Dr Lillian Min, an assistant professor in the division of geriatric drug at the University of Michigan Medical School, said in a university news release.
Thursday 20 March 2014
Scientists Have Found New Causes Of Stroke
Scientists Have Found New Causes Of Stroke.
Could desire aid the risk for stroke? A new long-term study suggests just that - the greater the anxiety, the greater the hazard for stroke. Study participants who suffered the most anxiety had a 33 percent higher imperil for stroke compared to those with the lowest anxiety levels, the researchers found. This is regard to be one of the first studies to show an association between anxiety and stroke. But not everyone is convinced the correlation is real. "I am a little skeptical about the results," said Dr Aviva Lubin, mate stroke director at Lenox Hill Hospital in New York City, who had no part in the study.
The researchers keen out that anxiety can be related to smoking and increased pulse and blood pressure, which are known peril factors for stroke. However, Lubin still has her doubts. "It still seems a little earnestly to fully buy into the fact that anxiety itself is a major risk factor that we need to deal with. Lubin said that treating endanger factors like smoking, high blood pressure and diabetes are the keys to preventing stroke.
And "I incredulity that treating anxiety itself is going to decrease the chance of stroke.The report was published Dec 19, 2013 in the online edition of the journal Stroke. The cramming was led by Maya Lambiase, a cardiovascular behavioral medicine researcher in the office of psychiatry at the University of Pittsburgh School of Medicine. Her team collected data on more than 6000 commonality aged 25 to 74 when they enrolled in the first US National Health and Nutrition Examination Survey, started in the first 1970s.
Could desire aid the risk for stroke? A new long-term study suggests just that - the greater the anxiety, the greater the hazard for stroke. Study participants who suffered the most anxiety had a 33 percent higher imperil for stroke compared to those with the lowest anxiety levels, the researchers found. This is regard to be one of the first studies to show an association between anxiety and stroke. But not everyone is convinced the correlation is real. "I am a little skeptical about the results," said Dr Aviva Lubin, mate stroke director at Lenox Hill Hospital in New York City, who had no part in the study.
The researchers keen out that anxiety can be related to smoking and increased pulse and blood pressure, which are known peril factors for stroke. However, Lubin still has her doubts. "It still seems a little earnestly to fully buy into the fact that anxiety itself is a major risk factor that we need to deal with. Lubin said that treating endanger factors like smoking, high blood pressure and diabetes are the keys to preventing stroke.
And "I incredulity that treating anxiety itself is going to decrease the chance of stroke.The report was published Dec 19, 2013 in the online edition of the journal Stroke. The cramming was led by Maya Lambiase, a cardiovascular behavioral medicine researcher in the office of psychiatry at the University of Pittsburgh School of Medicine. Her team collected data on more than 6000 commonality aged 25 to 74 when they enrolled in the first US National Health and Nutrition Examination Survey, started in the first 1970s.
Monday 17 March 2014
Scientists Have Discovered What Robespierre Suffered
Scientists Have Discovered What Robespierre Suffered.
A commander of the French Revolution might have suffered from a choice immune system disorder in which the body starts to attack its own tissues and organs. Researchers created a facial reconstruction of Maximilien de Robespierre, using the confront cover made by Madame Tussaud after he was executed at the guillotine in 1794. They also reviewed historical documents on his medical history.
A commander of the French Revolution might have suffered from a choice immune system disorder in which the body starts to attack its own tissues and organs. Researchers created a facial reconstruction of Maximilien de Robespierre, using the confront cover made by Madame Tussaud after he was executed at the guillotine in 1794. They also reviewed historical documents on his medical history.
Saturday 15 March 2014
Fathers Raising Children
Fathers Raising Children.
Almost one in six fathers doesn't current with his children, according to budding research that looked at how involved dads are in their children's lives. "Men who live with their kids interact with them more. Just the contiguousness makes it easier," said study author Jo Jones, a statistician and demographer with the US National Centers for Health Statistics. "But significant portions of fathers who are not coresidential looseness with their children, breakfast with them and more on a daily basis.
There's a segment of non-coresidential dads who participate very actively," Jones said. "Then there are the coresidential dads who don't participate as much, although that's a much smaller part - only 1 or 2 percent. Living with children doesn't not abysmal a dad will be involved". Jones said other studies have shown that a father's involvement helps children academically and behaviorally.
And "Children whose fathers are complicated usually have better outcomes than children who don't have dads in their lives. The findings were published online Dec 20, 2013 in a record from the US Centers for Disease Control and Prevention. The investigate included a nationally emissary sample of more than 10000 men between the ages of 15 and 44, about half of whom were fathers. The boning up included adopted, biological and stepchildren.
The men were surveyed about their involvement with the children in their lives. Seventy-three percent of the fathers lived with their children, while another 11 percent had children they lived with as well as some they didn't stay with. Sixteen percent of the fathers had children they didn't viable with at all, according to the study. For children under the mature of 5, 72 percent of dads living at home fed or ate meals with their teenager daily, compared to about 8 percent of dads who didn't live with their unsophisticated children, the study found.
More older fathers, Hispanic fathers and dads with a high ready education or less reported not having eaten a meal with their children in the past four weeks. Ninety percent of fathers living with their green children bathed, diapered or dressed them, compared to 31 percent of dads who lived into pieces from their children. Older dads, Hispanic fathers and those with a pongy school diploma or less again were less likely to have participated in these activities, according to the study.
Dads who lived with young kids were six times more promising to read to them. For children between the ages of 5 and 18, 66 percent of dads who lived with their children ate meals with them every day, compared to about 3 percent of fathers who didn't dwell with their kids. Just 1,4 percent of dads living with older children reported not having eaten with their kids at all in the gone four weeks, compared to 53 percent of the dads who didn't subsist with the kids.
Almost one in six fathers doesn't current with his children, according to budding research that looked at how involved dads are in their children's lives. "Men who live with their kids interact with them more. Just the contiguousness makes it easier," said study author Jo Jones, a statistician and demographer with the US National Centers for Health Statistics. "But significant portions of fathers who are not coresidential looseness with their children, breakfast with them and more on a daily basis.
There's a segment of non-coresidential dads who participate very actively," Jones said. "Then there are the coresidential dads who don't participate as much, although that's a much smaller part - only 1 or 2 percent. Living with children doesn't not abysmal a dad will be involved". Jones said other studies have shown that a father's involvement helps children academically and behaviorally.
And "Children whose fathers are complicated usually have better outcomes than children who don't have dads in their lives. The findings were published online Dec 20, 2013 in a record from the US Centers for Disease Control and Prevention. The investigate included a nationally emissary sample of more than 10000 men between the ages of 15 and 44, about half of whom were fathers. The boning up included adopted, biological and stepchildren.
The men were surveyed about their involvement with the children in their lives. Seventy-three percent of the fathers lived with their children, while another 11 percent had children they lived with as well as some they didn't stay with. Sixteen percent of the fathers had children they didn't viable with at all, according to the study. For children under the mature of 5, 72 percent of dads living at home fed or ate meals with their teenager daily, compared to about 8 percent of dads who didn't live with their unsophisticated children, the study found.
More older fathers, Hispanic fathers and dads with a high ready education or less reported not having eaten a meal with their children in the past four weeks. Ninety percent of fathers living with their green children bathed, diapered or dressed them, compared to 31 percent of dads who lived into pieces from their children. Older dads, Hispanic fathers and those with a pongy school diploma or less again were less likely to have participated in these activities, according to the study.
Dads who lived with young kids were six times more promising to read to them. For children between the ages of 5 and 18, 66 percent of dads who lived with their children ate meals with them every day, compared to about 3 percent of fathers who didn't dwell with their kids. Just 1,4 percent of dads living with older children reported not having eaten with their kids at all in the gone four weeks, compared to 53 percent of the dads who didn't subsist with the kids.
Wednesday 12 March 2014
Diabetes Leads To A Stroke
Diabetes Leads To A Stroke.
Walking more is a undecorated way for nation at high risk for type 2 diabetes to greatly reduce their risk of heart disease, a renewed study suggests. Researchers analyzed data from more than 9300 adults with pre-diabetes in 40 countries. People with pre-diabetes have an increased gamble of cardiovascular events, such as heart attack and stroke. All of the examination participants were enrolled in programs meant to increase their physical activity, radiate excess pounds and cut fatty foods from their diets.
The participants' average number of steps infatuated per day was recorded at the start of the programs and again 12 months later. Amounts of walking at the origin of the programs and changes in amounts of walking over 12 months affected the participants' endanger of heart disease, according to the study, which was published Dec 19, 2013 in the journal The Lancet. For every 2000 steps more per prime a person took at the start of the study, they had a 10 percent bring risk for heart disease in subsequent years.
Walking more is a undecorated way for nation at high risk for type 2 diabetes to greatly reduce their risk of heart disease, a renewed study suggests. Researchers analyzed data from more than 9300 adults with pre-diabetes in 40 countries. People with pre-diabetes have an increased gamble of cardiovascular events, such as heart attack and stroke. All of the examination participants were enrolled in programs meant to increase their physical activity, radiate excess pounds and cut fatty foods from their diets.
The participants' average number of steps infatuated per day was recorded at the start of the programs and again 12 months later. Amounts of walking at the origin of the programs and changes in amounts of walking over 12 months affected the participants' endanger of heart disease, according to the study, which was published Dec 19, 2013 in the journal The Lancet. For every 2000 steps more per prime a person took at the start of the study, they had a 10 percent bring risk for heart disease in subsequent years.
Scientists Have Found A New Method Of Cancer Treatment
Scientists Have Found A New Method Of Cancer Treatment.
Blocking a main protein complicated in the growth of a rare, incurable type of soft-tissue cancer may ice the disease, according to a new study involving mice. Researchers from UT Southwestern found that inhibiting the power of a protein, known as BRD4, caused cancer cells in malignant peripheral impudence sheath tumors to die. Malignant peripheral nerve sheath tumors are highly assertive soft-tissue cancers, or sarcomas, that form around nerves.
And "This study identifies a potential unfledged therapeutic target to combat malignant peripheral nerve sheath tumor, an incurable genre of cancer that is typically fatal," study senior author Dr Lu Le, an deputy professor of dermatology, said in a university news release. "The findings also provide leading insight into what causes these tumors to develop". The findings were published online Dec 26, 2013 in the daily Cell Reports.
Although malignant peripheral nerve sheath tumors can amplify randomly, about 50 percent of cases involve patients with a genetic disorder called neurofibromatosis category 1. This disorder affects one in 3500 people. About 10 percent of those patients will go on to reveal the soft-tissue cancer, according to the news release. For the study, the researchers examined changes in cells as they evolved into cancerous soft-tissue tumors.
Blocking a main protein complicated in the growth of a rare, incurable type of soft-tissue cancer may ice the disease, according to a new study involving mice. Researchers from UT Southwestern found that inhibiting the power of a protein, known as BRD4, caused cancer cells in malignant peripheral impudence sheath tumors to die. Malignant peripheral nerve sheath tumors are highly assertive soft-tissue cancers, or sarcomas, that form around nerves.
And "This study identifies a potential unfledged therapeutic target to combat malignant peripheral nerve sheath tumor, an incurable genre of cancer that is typically fatal," study senior author Dr Lu Le, an deputy professor of dermatology, said in a university news release. "The findings also provide leading insight into what causes these tumors to develop". The findings were published online Dec 26, 2013 in the daily Cell Reports.
Although malignant peripheral nerve sheath tumors can amplify randomly, about 50 percent of cases involve patients with a genetic disorder called neurofibromatosis category 1. This disorder affects one in 3500 people. About 10 percent of those patients will go on to reveal the soft-tissue cancer, according to the news release. For the study, the researchers examined changes in cells as they evolved into cancerous soft-tissue tumors.
Tuesday 4 March 2014
Children Survive After A Liver Transplant
Children Survive After A Liver Transplant.
White children in the United States have higher liver relocate survival rates than blacks and other minority children, a additional learn finds. Researchers looked at 208 patients, aged 22 and younger, who received a liver resettle at Children's Hospital of Atlanta between January 1998 and December 2008. Fifty-one percent of the patients were white, 35 percent were black, and 14 percent were other races.
At one, three, five and 10 years after transplant, tool and accommodating survival was higher centre of white recipients than among minority recipients, the investigators found. The 10-year element survival rate was 84 percent among whites, 60 percent among blacks and 49 percent mid other races. The 10-year patient survival rate was 92 percent for whites, 65 percent for blacks and 76 percent amidst other races.
White children in the United States have higher liver relocate survival rates than blacks and other minority children, a additional learn finds. Researchers looked at 208 patients, aged 22 and younger, who received a liver resettle at Children's Hospital of Atlanta between January 1998 and December 2008. Fifty-one percent of the patients were white, 35 percent were black, and 14 percent were other races.
At one, three, five and 10 years after transplant, tool and accommodating survival was higher centre of white recipients than among minority recipients, the investigators found. The 10-year element survival rate was 84 percent among whites, 60 percent among blacks and 49 percent mid other races. The 10-year patient survival rate was 92 percent for whites, 65 percent for blacks and 76 percent amidst other races.
Friday 28 February 2014
Improve The Treatment Of PTSD Can Be Through The Amygdala
Improve The Treatment Of PTSD Can Be Through The Amygdala.
Researchers who have deliberate a piece with a missing amygdala - the part of the brain believed to form fear - report that their findings may help improve treatment for post-traumatic ictus disorder (PTSD) and other anxiety disorders. In perhaps the first human study confirming that the almond-shaped build is crucial for triggering fear, researchers at the University of Iowa monitored a 44-year-old woman's comeback to typically frightening stimuli such as snakes, spiders, horror films and a haunted house, and asked about upsetting experiences in her past. The woman, identified as SM, does not seem to anxiety a wide range of stimuli that would normally frighten most people.
Scientists have been studying her for the past 20 years, and their previous research had already determined that the woman cannot recognize fear in others' facial expressions. SM suffers from an hellishly rare disease that destroyed her amygdala. Future observations will determine if her adapt affects anxiety levels for everyday stressors such as finance or health issues, said scrutiny author Justin Feinstein, a University of Iowa doctoral student studying clinical neuropsychology. "Certainly, when it comes to fear, she's missing it," Feinstein said. "She's so single in her presentation".
Researchers said the study, reported in the Dec 16, 2010 outflow of the journal Current Biology, could advanced position to new treatment strategies for PTSD and anxiety disorders. According to the US National Institute of Mental Health, more than 7,7 million Americans are mannered by the condition, and a 2008 division predicted that 300000 soldiers returning from combat in the Middle East would experience PTSD. "Because of her cognition damage, the patient appears to be immune to PTSD," Feinstein said, noting that she is otherwise cognitively normal and experiences other emotions such as happiness and sadness.
In addition to recording her responses to spiders, snakes and other unnerving stimuli, the researchers measured her experience of fear using many standardized questionnaires that probed various aspects of the emotion, such as respect of death or fear of public speaking. She also carried a computerized sensation diary for three months that randomly asked her to rate her fear level throughout the day.
Researchers who have deliberate a piece with a missing amygdala - the part of the brain believed to form fear - report that their findings may help improve treatment for post-traumatic ictus disorder (PTSD) and other anxiety disorders. In perhaps the first human study confirming that the almond-shaped build is crucial for triggering fear, researchers at the University of Iowa monitored a 44-year-old woman's comeback to typically frightening stimuli such as snakes, spiders, horror films and a haunted house, and asked about upsetting experiences in her past. The woman, identified as SM, does not seem to anxiety a wide range of stimuli that would normally frighten most people.
Scientists have been studying her for the past 20 years, and their previous research had already determined that the woman cannot recognize fear in others' facial expressions. SM suffers from an hellishly rare disease that destroyed her amygdala. Future observations will determine if her adapt affects anxiety levels for everyday stressors such as finance or health issues, said scrutiny author Justin Feinstein, a University of Iowa doctoral student studying clinical neuropsychology. "Certainly, when it comes to fear, she's missing it," Feinstein said. "She's so single in her presentation".
Researchers said the study, reported in the Dec 16, 2010 outflow of the journal Current Biology, could advanced position to new treatment strategies for PTSD and anxiety disorders. According to the US National Institute of Mental Health, more than 7,7 million Americans are mannered by the condition, and a 2008 division predicted that 300000 soldiers returning from combat in the Middle East would experience PTSD. "Because of her cognition damage, the patient appears to be immune to PTSD," Feinstein said, noting that she is otherwise cognitively normal and experiences other emotions such as happiness and sadness.
In addition to recording her responses to spiders, snakes and other unnerving stimuli, the researchers measured her experience of fear using many standardized questionnaires that probed various aspects of the emotion, such as respect of death or fear of public speaking. She also carried a computerized sensation diary for three months that randomly asked her to rate her fear level throughout the day.
Thursday 27 February 2014
Surgeons Found The Role Of Obesity In Cancer
Surgeons Found The Role Of Obesity In Cancer.
Obesity and smoking growth the imperil of implant failure in women who undergo breast reconstruction soon after chest removal, according to a new study. Researchers analyzed data from nearly 15000 women, aged 40 to 60, who had reflex reconstruction after breast removal (mastectomy). They found that the risk of implant failure was three times higher in smokers and two to three times higher in obese women. The more heavy a woman, the greater her risk of early implant failure, according to the study, which was published in the December spring of the Journal of the American College of Surgeons.
Other factors associated with a higher peril of implant loss included being older than 55, receiving implants in both breasts, and undergoing both boob removal and reconstruction with implants in a single operation. "Less than 1 percent of all patients in our chew over experienced implant failure ," study lead author Dr John Fischer, a inexperienced surgery resident at the Perelman School of Medicine at the University of Pennsylvania, said in a dossier news release.
Obesity and smoking growth the imperil of implant failure in women who undergo breast reconstruction soon after chest removal, according to a new study. Researchers analyzed data from nearly 15000 women, aged 40 to 60, who had reflex reconstruction after breast removal (mastectomy). They found that the risk of implant failure was three times higher in smokers and two to three times higher in obese women. The more heavy a woman, the greater her risk of early implant failure, according to the study, which was published in the December spring of the Journal of the American College of Surgeons.
Other factors associated with a higher peril of implant loss included being older than 55, receiving implants in both breasts, and undergoing both boob removal and reconstruction with implants in a single operation. "Less than 1 percent of all patients in our chew over experienced implant failure ," study lead author Dr John Fischer, a inexperienced surgery resident at the Perelman School of Medicine at the University of Pennsylvania, said in a dossier news release.
Development Of Tablets To Reduce The Desire For High-Calorie Food
Development Of Tablets To Reduce The Desire For High-Calorie Food.
You're dieting, and you positive you should retard away from high-calorie snacks. Yet, your eyes muzzle straying toward that box of chocolates, and you wish there was a pill to restrain your impulse to inhale them. Such a capsule might one day be a real possibility, according to findings presented Tuesday at the Endocrine Society's annual assignation in San Diego. It would block the activity of ghrelin, the "hunger hormone" that stimulates the passion centers of the brain.
The study, reported by Dr Tony Goldstone, a consultant endocrinologist at the British Medical Research Council Clinical Sciences Center at Imperial College London, showed that ghrelin does mother the hanker after for high-calorie foods in humans. "It's been known from animal and beneficent work that ghrelin makes people hungrier," Goldstone said. "There has been a suspicion from mammal work that it can also stimulate the rewards pathways of the brain and may be involved in the response to more rewarding foods, but we didn't have indication of that in people".
The study that provided such evidence had 18 healthy adults look at pictures of unlike foods on three mornings, once after skipping breakfast and twice about 90 minutes after having breakfast. On one of the breakfast-eating mornings, all the participants got injections - some of soused water, some of ghrelin. Then they looked at pictures of high-calorie foods such as chocolate, bar and pizza, and low-calorie foods such as salads and vegetables.
The participants in use a keyboard to rate the appeal of those pictures. Low-calorie foods were rated about the same, no purport what was in the injections. But the high-calorie foods, especially sweets, rated higher in those who got ghrelin. "It seems to vary the desire for high-calorie foods more than low-calorie foods," Goldstone said of ghrelin.
You're dieting, and you positive you should retard away from high-calorie snacks. Yet, your eyes muzzle straying toward that box of chocolates, and you wish there was a pill to restrain your impulse to inhale them. Such a capsule might one day be a real possibility, according to findings presented Tuesday at the Endocrine Society's annual assignation in San Diego. It would block the activity of ghrelin, the "hunger hormone" that stimulates the passion centers of the brain.
The study, reported by Dr Tony Goldstone, a consultant endocrinologist at the British Medical Research Council Clinical Sciences Center at Imperial College London, showed that ghrelin does mother the hanker after for high-calorie foods in humans. "It's been known from animal and beneficent work that ghrelin makes people hungrier," Goldstone said. "There has been a suspicion from mammal work that it can also stimulate the rewards pathways of the brain and may be involved in the response to more rewarding foods, but we didn't have indication of that in people".
The study that provided such evidence had 18 healthy adults look at pictures of unlike foods on three mornings, once after skipping breakfast and twice about 90 minutes after having breakfast. On one of the breakfast-eating mornings, all the participants got injections - some of soused water, some of ghrelin. Then they looked at pictures of high-calorie foods such as chocolate, bar and pizza, and low-calorie foods such as salads and vegetables.
The participants in use a keyboard to rate the appeal of those pictures. Low-calorie foods were rated about the same, no purport what was in the injections. But the high-calorie foods, especially sweets, rated higher in those who got ghrelin. "It seems to vary the desire for high-calorie foods more than low-calorie foods," Goldstone said of ghrelin.
Monday 24 February 2014
Controversial Guidelines Of Treatment Of Lyme Disease Is Left In Action
Controversial Guidelines Of Treatment Of Lyme Disease Is Left In Action.
After more than a year of study, a expressly appointed panel at the Infectious Diseases Society of America has unquestionable that argumentative guidelines for the treatment of Lyme disease are correct and have occasion for not be changed. The guidelines, first adopted in 2006, have long advocated for the short-term (less than a month) antibiotic curing of new infections of Lyme disease, which is caused by Borrelia burgdorferi, a bacteria transmitted to humans via tick bites.
However, the guidelines have also been the cynosure of fierce antipathy from certain patient advocate groups that believe there is a debilitating, "chronic" form of Lyme affliction requiring much longer therapy. The IDSA guidelines are important because doctors and insurance companies often follow them when making care (and treatment reimbursement) decisions.
The new review was sparked by an review launched by Connecticut Attorney General Richard Blumenthal, whose office had concerns about the process cast-off to draft the guidelines. "This was the first challenge to any of the infectious disease guidelines" the Society has issued over the years, IDSA president Dr Richard Whitley said during a host conference held Thursday.
Whitley eminent that the special panel was put together with an independent medical ethicist, Dr Howard Brody, from the University of Texas Medical Branch, who was approved by Blumenthal so that the body would be sure to have no conflicts of interest. The guidelines check 69 recommendations, Dr Carol J Baker, stool of the Review Panel, and pediatric infectious diseases specialist at Baylor College of Medicine, said during the cluster conference.
So "For each of these recommendations our review panel found that each was medically and scientifically justified in torch of all the evidence and information and required no revision," she said. For all but one of the votes the committee agreed unanimously, Baker added.
Particularly on the continued use of antibiotics, the panel had concerns that prolonged use of these drugs puts patients in threat of precarious infection while not improving their condition, Baker said. "In the case of Lyme disease, there has yet to be a unique high-quality clinical study that demonstrates comparable benefit to prolonging antibiotic treatment beyond one month," the panel members found.
After more than a year of study, a expressly appointed panel at the Infectious Diseases Society of America has unquestionable that argumentative guidelines for the treatment of Lyme disease are correct and have occasion for not be changed. The guidelines, first adopted in 2006, have long advocated for the short-term (less than a month) antibiotic curing of new infections of Lyme disease, which is caused by Borrelia burgdorferi, a bacteria transmitted to humans via tick bites.
However, the guidelines have also been the cynosure of fierce antipathy from certain patient advocate groups that believe there is a debilitating, "chronic" form of Lyme affliction requiring much longer therapy. The IDSA guidelines are important because doctors and insurance companies often follow them when making care (and treatment reimbursement) decisions.
The new review was sparked by an review launched by Connecticut Attorney General Richard Blumenthal, whose office had concerns about the process cast-off to draft the guidelines. "This was the first challenge to any of the infectious disease guidelines" the Society has issued over the years, IDSA president Dr Richard Whitley said during a host conference held Thursday.
Whitley eminent that the special panel was put together with an independent medical ethicist, Dr Howard Brody, from the University of Texas Medical Branch, who was approved by Blumenthal so that the body would be sure to have no conflicts of interest. The guidelines check 69 recommendations, Dr Carol J Baker, stool of the Review Panel, and pediatric infectious diseases specialist at Baylor College of Medicine, said during the cluster conference.
So "For each of these recommendations our review panel found that each was medically and scientifically justified in torch of all the evidence and information and required no revision," she said. For all but one of the votes the committee agreed unanimously, Baker added.
Particularly on the continued use of antibiotics, the panel had concerns that prolonged use of these drugs puts patients in threat of precarious infection while not improving their condition, Baker said. "In the case of Lyme disease, there has yet to be a unique high-quality clinical study that demonstrates comparable benefit to prolonging antibiotic treatment beyond one month," the panel members found.
Monday 17 February 2014
Sulfonylurea Drugs Increase The Risk Of Heart Disease
Sulfonylurea Drugs Increase The Risk Of Heart Disease.
New experiment with shows that older ladies and gentlemen with type 2 diabetes who take drugs known as sulfonylureas to humble their blood sugar levels may face a higher risk for heart problems than their counterparts who induce metformin. Of the more than 8500 people aged 65 or older with breed 2 diabetes who were enrolled in the trial, 12,4 percent of those given a sulfonylurea drug experienced a middle attack or other cardiovascular event, compared with 10,4 percent of those who were started on metformin. In addition, these heartlessness problems occurred earlier in the course of treatment among those people taking the sulfonylurea drugs, the lessons showed.
The head-to-head comparison trial is slated to be presented Saturday at the American Diabetes Association annual tryst in San Diego. Because the findings are being reported at a medical meeting, they should be considered preparation until published in a peer-reviewed journal. With type 2 diabetes, the body either does not spark enough of the hormone insulin or doesn't use the insulin it does produce properly.
In either case, the insulin can't do its job, which is to throw glucose (blood sugar) to the body's cells. As a result, glucose builds up in the blood and can impose havoc on the body. Metformin and sulfonylurea drugs - the latter a stock of diabetes drugs including glyburide, glipizide, chlorpropamide, tolbutamide and tolazamide - are often among the first medications prescribed to lower blood sugar levels in people with type 2 diabetes.
The findings are important, the researchers noted, partly because sulfonylurea drugs are commonly prescribed middle the senile to lower blood glucose levels. In addition, cardiovascular sickness is the leading cause of death among people with type 2 diabetes. For several reasons, however, the strange study on these medications is far from the final word on the issue, experts said.
For one, men and women who are started on the sulfonylureas instead of metformin are often sicker to begin with, said Dr Spyros G Mezitis, an endocrinologist at Lenox Hill Hospital in New York City. Metformin cannot be prescribed to kinfolk with firm kidney and heart problems, he said. Both medications lower blood glucose levels, but go about it in clearly different ways, he explained.
New experiment with shows that older ladies and gentlemen with type 2 diabetes who take drugs known as sulfonylureas to humble their blood sugar levels may face a higher risk for heart problems than their counterparts who induce metformin. Of the more than 8500 people aged 65 or older with breed 2 diabetes who were enrolled in the trial, 12,4 percent of those given a sulfonylurea drug experienced a middle attack or other cardiovascular event, compared with 10,4 percent of those who were started on metformin. In addition, these heartlessness problems occurred earlier in the course of treatment among those people taking the sulfonylurea drugs, the lessons showed.
The head-to-head comparison trial is slated to be presented Saturday at the American Diabetes Association annual tryst in San Diego. Because the findings are being reported at a medical meeting, they should be considered preparation until published in a peer-reviewed journal. With type 2 diabetes, the body either does not spark enough of the hormone insulin or doesn't use the insulin it does produce properly.
In either case, the insulin can't do its job, which is to throw glucose (blood sugar) to the body's cells. As a result, glucose builds up in the blood and can impose havoc on the body. Metformin and sulfonylurea drugs - the latter a stock of diabetes drugs including glyburide, glipizide, chlorpropamide, tolbutamide and tolazamide - are often among the first medications prescribed to lower blood sugar levels in people with type 2 diabetes.
The findings are important, the researchers noted, partly because sulfonylurea drugs are commonly prescribed middle the senile to lower blood glucose levels. In addition, cardiovascular sickness is the leading cause of death among people with type 2 diabetes. For several reasons, however, the strange study on these medications is far from the final word on the issue, experts said.
For one, men and women who are started on the sulfonylureas instead of metformin are often sicker to begin with, said Dr Spyros G Mezitis, an endocrinologist at Lenox Hill Hospital in New York City. Metformin cannot be prescribed to kinfolk with firm kidney and heart problems, he said. Both medications lower blood glucose levels, but go about it in clearly different ways, he explained.
Thursday 13 February 2014
A New Drug For The Treatment Of Skin Cancer Increases The Survival Of Patients
A New Drug For The Treatment Of Skin Cancer Increases The Survival Of Patients.
Scientists give the word that a imaginative drug to bonus melanoma, the first in its class, improved survival by 68 percent in patients whose disease had blanket from the skin to other parts of the body. This is big news in the field of melanoma research, where survival rates have refused to budge, in spite of numerous efforts to come up with an effective treatment for the increasingly common and harmful skin cancer over the past three decades. "The last time a drug was approved for metastatic melanoma was 12 years ago, and 85 percent of woman in the street who take that slip have no benefit, so finding another drug that is going to have an impact, and even a bigger impact than what's out there now, is a vital improvement for patients," said Timothy Turnham, executive director of the Melanoma Research Foundation in Washington, DC.
The findings on the drug, called ipilimumab, were reported simultaneously Saturday at the annual engagement of the American Society of Clinical Oncology (ASCO) in Chicago and in the June 5 online young of the New England Journal of Medicine. Ipilimumab is the principal in a new class of targeted T-cell antibodies, with possibility applications for other cancers as well.
Both the incidence of metastatic melanoma and the eradication rate have risen during the past 30 years, and patients with advanced disease typically have small treatment options. "Ipilimumab is a human monoclonal antibody directed against CTLA-4, which is on the surface of T-cells which fray infection ," explained lead study author Dr Steven O'Day, top dog of the melanoma program at the Angeles Clinic and Research Institute in Los Angeles. "CTL is a very notable break to the immune system, so by blocking this break with ipilimumab, it accelerates and potentiates the T-cells. And by doing that they become activated and can go out and use up the cancer.
Scientists give the word that a imaginative drug to bonus melanoma, the first in its class, improved survival by 68 percent in patients whose disease had blanket from the skin to other parts of the body. This is big news in the field of melanoma research, where survival rates have refused to budge, in spite of numerous efforts to come up with an effective treatment for the increasingly common and harmful skin cancer over the past three decades. "The last time a drug was approved for metastatic melanoma was 12 years ago, and 85 percent of woman in the street who take that slip have no benefit, so finding another drug that is going to have an impact, and even a bigger impact than what's out there now, is a vital improvement for patients," said Timothy Turnham, executive director of the Melanoma Research Foundation in Washington, DC.
The findings on the drug, called ipilimumab, were reported simultaneously Saturday at the annual engagement of the American Society of Clinical Oncology (ASCO) in Chicago and in the June 5 online young of the New England Journal of Medicine. Ipilimumab is the principal in a new class of targeted T-cell antibodies, with possibility applications for other cancers as well.
Both the incidence of metastatic melanoma and the eradication rate have risen during the past 30 years, and patients with advanced disease typically have small treatment options. "Ipilimumab is a human monoclonal antibody directed against CTLA-4, which is on the surface of T-cells which fray infection ," explained lead study author Dr Steven O'Day, top dog of the melanoma program at the Angeles Clinic and Research Institute in Los Angeles. "CTL is a very notable break to the immune system, so by blocking this break with ipilimumab, it accelerates and potentiates the T-cells. And by doing that they become activated and can go out and use up the cancer.
Subscribe to:
Posts (Atom)